The transgenic shared resource was founded in 1988 to train and assist AECC investigators in the production and characterization of transgenic mouse strains. This technology allows analysis of gene function through the introduction of DMA sequences into the germ line, usually, although not exclusively, by pronuclear injection of fertilized oocytes. The shared resource supervisor director consults with individual investigators and advises on transgene construct, as well as making plasmids and sequence cassettes available, as well as other reagents. This results in DMA constructs suitable for expression in the mouse. Usually this is in the form of a plasmid but we also offer the injection of BAG DMA. The shared resource prepares the DNA and introduces this DNA into the oocytes by micro-injection. In some cases the sequence of interest is introduced into the oocyte by lentivirus infection. After the manipulation of the oocyte they are transferred to pseudo-pregnant mothers and following birth, the pups are cared for to weaning. At this point mice are returned to the investigator for further analysis. The production of useful transgenics usually takes less than seven weeks from submission of the DNA. We guarantee at least three founders per construct although generally more are generated. We have had essentially 100% success rate with little need for reinjection of constructs, Between 18-25 investigators use this service per year with approximately 100 constructs injected. In addition, the core provides embryo and sperm freezing for long-term storage of mouse lines, in vitro fertilization (IVF) and intra-cytoplasmic sperm injections (ICSI) to rescue frozen samples or difficult to mate strains. We also provide blastomere fusion to generate tetraploid embryos for aggregation with ES cells to determine whether the phenotypes of mutations are intrinsic to the embryo or are the result of placenta! abnormalities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-39
Application #
8294860
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2013-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
39
Fiscal Year
2011
Total Cost
$248,050
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131

Showing the most recent 10 out of 1508 publications